Professor Paul Hofman, Director of RespirERA Institute, has joined the new international journal Precision Diagnostics in Oncology as an Associate Editor. This editorial role is closely aligned with his work in molecular pathology, biomarkers and precision oncology.
A new journal dedicated to precision diagnostics
Precision Diagnostics in Oncology is a new international, peer-reviewed, open-access scientific journal published by BMC, part of Springer Nature. It focuses on quantitative technologies and approaches designed to improve the precision of diagnostic analyses in oncology.
Its scope includes multi-omics approaches, which combine different types of biological data, as well as digital and computational pathology, artificial intelligence applications in diagnostics and biomarker discovery.
The journal also addresses ethical and regulatory issues related to the use of data, particularly data privacy. It welcomes original research articles, reviews, methodological papers and scientific comments.
Professor Paul Hofman appointed as Associate Editor
Professor Paul Hofman, Director of RespirERA Institute and Professor at Université Côte d’Azur, is one of the journal’s Associate Editors. He joins an international editorial board led by Professor Michael Roehrl of Harvard Medical School and Beth Israel Deaconess Medical Center in Boston.
This editorial responsibility is closely aligned with Professor Paul Hofman’s expertise in molecular pathology, biomarkers, liquid biopsy and precision diagnostics in oncology, particularly thoracic oncology.
As a member of the editorial board, he will contribute to international scientific discussions on methods designed to improve the characterisation of cancers and their associated biological information.
Supporting the international reach of RespirERA’s expertise
For RespirERA Institute, this new responsibility will help raise the international profile of expertise developed in Nice in diagnostic technologies and the analysis of complex oncology data.
It also strengthens the institute’s links with an international scientific community working to improve diagnostic quality, identify relevant biomarkers and develop new technological approaches.
FR 
EN 